ProPhase LLC Hires Kris Kuhner as Vice President of Business Development

NEW YORK, NY--(Marketwired - Feb 6, 2014) - ProPhase LLC today announced that Kris Kuhner has joined the company to head business development. Kuhner has over 14 years of industry experience in pharmaceutical and clinical research.

Kuhner joins as vice president of business development to build on ProPhase's recent commercial successes in partnering to deliver highly customized solutions that support clinical trials in over 60 countries, in all phases, across 18 primary indications. 

"As a new member to ProPhase, I'm excited to be involved with such a dynamic group that is committed to delivering unique solutions back to sponsors and because of their science first approach where the key factors include delivering a quality-based approach on maximizing endpoints and goals within each protocol," said Kuhner. "Our goal is to be the best in our space focusing on all services in support of measurement related activities in clinical trials."

Kuhner worked for Astra Zeneca, Wyeth and ICON. His diversity of experience spans clinical operations and commercial leadership roles, across CNS, oncology and cardiovascular programs. Kuhner has been instrumental in the development of new business and strategies, resulting in the establishment of large strategic partnerships, while driving and exceeding annual growth targets. He has a proven track record of directing and overseeing accounts and motivating team members to succeed. Kuhner obtained a Bachelors of Science in Biology from Dickinson College.

"We're thrilled about the arrival of Mr. Kuhner, who brings significant experience and is an industry leader in his domain," said Mark Opler, CEO. "His unrivaled reputation and experience at the sponsor, CRO, and vendor level gives him a unique perspective on business development and alliance partnerships."

"We're looking to Kris to further develop our strategic partnerships with both sponsors and CROs and deepen those relationships to help us deliver superior results," said Sofija Jovic, president and COO. "In an increasingly complex environment, Kris' leadership will ensure that ProPhase continues to redefine the standard of smart measurement in CNS and beyond."

About ProPhase LLC
Prophase is a specialty services organization focusing on applied measurement in CNS (psychiatry, neurology, sleep and pain disorders, and rare/orphan diseases). ProPhase's services support all measurement-related activities in clinical trials and their industry experience is unparalleled. For more information visit www.prophase.com.